These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 115249)

  • 1. Plasma exchange in nephritis.
    Lockwood CM; Pussell B; Wilson CB; Peters DK
    Adv Nephrol Necker Hosp; 1979; 8():383-418. PubMed ID: 115249
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma exchange in progressive lupus nephritis].
    Hörmann A; Keusch G; Burger R; Briner J; Binswanger U; Gmür J
    Schweiz Med Wochenschr; 1982 Jun; 112(24):853-8. PubMed ID: 7112055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic plasma exchange therapy in SLE nephritis.
    Clark WF; Lindsay RM; Ulan RA; Cordy PE; Linton AL
    Clin Nephrol; 1981 Jul; 16(1):20-3. PubMed ID: 7273493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "End-stage" lupus nephritis: clinical course to and outcome on dialysis. Experience with 39 patients.
    Kimberly RP; Lockshin MD; Sherman RL; Beary JF; Mouradian J; Cheigh JS
    Medicine (Baltimore); 1981 Jul; 60(4):277-87. PubMed ID: 7242321
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinico-immunological evaluation of the activity of total complement of the blood serum of patients with systemic lupus erythematosus].
    Zhuravlev GI; Rodshtein OA
    Ter Arkh; 1972 Nov; 44(11):29-33. PubMed ID: 4125143
    [No Abstract]   [Full Text] [Related]  

  • 7. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum complement levels in nephritis].
    Igaki Y
    Arerugi; 1967 Apr; 16(4):249-69. PubMed ID: 5624240
    [No Abstract]   [Full Text] [Related]  

  • 9. The patient with lupus nephritis: a nursing perspective.
    Joyce KM; Austin HA; Balow JE
    Heart Lung; 1985 Jan; 14(1):75-9. PubMed ID: 3844006
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression.
    Leaker BR; Becker GJ; Dowling JP; Kincaid-Smith PS
    Clin Nephrol; 1986 May; 25(5):236-44. PubMed ID: 3720034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of lupus nephritis in childhood].
    Taubert M; Döring E
    Padiatr Grenzgeb; 1983; 22(2-3):191-4. PubMed ID: 6888932
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nephritis and the presence of antiribonucleoprotein antibodies in disseminated lupus erythematosus in children and adolescents].
    Lapointe ND; Carrenö-Perrez L; Pelletier M; Déom P; Robitaille P
    Union Med Can; 1985 Jun; 114(6):490-2. PubMed ID: 3875176
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma exchange in immune complex disease.
    Houwert DA; Kater L; Hené RJ; Struyvenberg A
    Proc Eur Dial Transplant Assoc; 1979; 16():520-7. PubMed ID: 162005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute kidney failure in lupus nephritis in children and adolescents].
    Kartasheva VI; Sorokina MI
    Pediatriia; 1981 Apr; (4):34-7. PubMed ID: 7255026
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal insufficiency in lupus nephritis.
    Boelaert J; Morel-Maroger L; Méry JP
    Adv Nephrol Necker Hosp; 1974; 4():249-89. PubMed ID: 4219996
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological analysis of minimal change nephrotic syndrome and lupus nephritis: sensitivity of suppressor cells to indomethacin.
    Osaki K
    Nihon Jinzo Gakkai Shi; 1986 Mar; 28(3):255-62. PubMed ID: 2941607
    [No Abstract]   [Full Text] [Related]  

  • 17. The measurement of complement as an aid in diagnosis: 1. Nephritis and collagen disease.
    McKay EJ; Haines DJ
    N Z Med J; 1978 May; 87(611):315-8. PubMed ID: 276704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphocytapheresis therapy. 3. Systemic lupus erythematosus].
    Hashimoto H; Tsuda H; Yokoyama S; Yamagata S; Herano T
    Rinsho Ketsueki; 1985 Nov; 26(11):1892-7. PubMed ID: 3835298
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased synthesis of the third component of complement (C3) in hypocomplementemic systemic lupus erythematosus.
    Sliwinski AJ; Zvaifler NJ
    Clin Exp Immunol; 1972 May; 11(1):21-9. PubMed ID: 5038771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of plasmapheresis in active systemic lupus erythematosus.
    Kater L; Derksen RH; Houwert DA; Hené RJ; Struyvenberg A; Gmelig Meyling FH; Verroust P
    Neth J Med; 1981; 24(6):209-16. PubMed ID: 7322246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.